Want to join the conversation?
Global pharmaceutical giant $ABBV today got the approval of VIEKIRAX from Japanese Ministry of Health, Labour and Welfare for the treatment of adult patients with HCV-1 infection, including those with compensated liver cirrhosis. With this approval, $ABBV is going to address the unmet need of approx. 2MM HCV patients in Japan.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.